国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Rat Vomeronasal type-1 receptor 52 (Vmn1r52), partial CSB-YP702447RA1
CSB-EP702447RA1
CSB-BP702447RA1
CSB-MP702447RA1
CSB-EP702447RA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca mulatta Beta-defensin 121 (DEFB121) CSB-YP702448MOW
CSB-EP702448MOW
CSB-BP702448MOW
CSB-MP702448MOW
CSB-EP702448MOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Probable tRNA sulfurtransferase (thiI) CSB-YP702449FHY
CSB-EP702449FHY
CSB-BP702449FHY
CSB-MP702449FHY
CSB-EP702449FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis tRNA-splicing ligase RtcB (rtcB) CSB-YP702450FHY
CSB-EP702450FHY
CSB-BP702450FHY
CSB-MP702450FHY
CSB-EP702450FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis IMP cyclohydrolase (purO) CSB-YP702451FHY
CSB-EP702451FHY
CSB-BP702451FHY
CSB-MP702451FHY
CSB-EP702451FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Cysteine--tRNA ligase (cysS) CSB-YP702452FHY
CSB-EP702452FHY
CSB-BP702452FHY
CSB-MP702452FHY
CSB-EP702452FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis 50S ribosomal protein L2P (rpl2p) CSB-YP702453FHY
CSB-EP702453FHY
CSB-BP702453FHY
CSB-MP702453FHY
CSB-EP702453FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Proteasome subunit beta 1 (psmB1) CSB-YP702454FHY
CSB-EP702454FHY
CSB-BP702454FHY
CSB-MP702454FHY
CSB-EP702454FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis V-type ATP synthase subunit C (atpC) CSB-YP702455FHY
CSB-EP702455FHY
CSB-BP702455FHY
CSB-MP702455FHY
CSB-EP702455FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis DNA-directed RNA polymerase subunit H (rpoH) CSB-YP702456FHY
CSB-EP702456FHY
CSB-BP702456FHY
CSB-MP702456FHY
CSB-EP702456FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Molybdate/tungstate import ATP-binding protein WtpC (wtpC) CSB-YP702457FHY
CSB-EP702457FHY
CSB-BP702457FHY
CSB-MP702457FHY
CSB-EP702457FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Galactokinase (galK) CSB-YP702458FHY
CSB-EP702458FHY
CSB-BP702458FHY
CSB-MP702458FHY
CSB-EP702458FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis UPF0130 protein TK1907 (TK1907) CSB-YP702459FHY
CSB-EP702459FHY
CSB-BP702459FHY
CSB-MP702459FHY
CSB-EP702459FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Probable deoxyhypusine synthase (dys) CSB-YP702460FHY
CSB-EP702460FHY
CSB-BP702460FHY
CSB-MP702460FHY
CSB-EP702460FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Superoxide reductase (sorA) CSB-YP702461FHY
CSB-EP702461FHY
CSB-BP702461FHY
CSB-MP702461FHY
CSB-EP702461FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis DNA/RNA-binding protein Alba (albA) CSB-YP702462FHY
CSB-EP702462FHY
CSB-BP702462FHY
CSB-MP702462FHY
CSB-EP702462FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis UPF0173 metal-dependent hydrolase TK0141 (TK0141) CSB-YP702463FHY
CSB-EP702463FHY
CSB-BP702463FHY
CSB-MP702463FHY
CSB-EP702463FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis GMP synthase [glutamine-hydrolyzing] subunit B (guaAB) CSB-YP702464FHY
CSB-EP702464FHY
CSB-BP702464FHY
CSB-MP702464FHY
CSB-EP702464FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Phosphoribosylformylglycinamidine synthase 1 (purQ) CSB-YP702465FHY
CSB-EP702465FHY
CSB-BP702465FHY
CSB-MP702465FHY
CSB-EP702465FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis ATP phosphoribosyltransferase (hisG) CSB-YP702466FHY
CSB-EP702466FHY
CSB-BP702466FHY
CSB-MP702466FHY
CSB-EP702466FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>